FDA Approves Rybelsus (semaglutide), the First Oral GLP-1 Analog Treatment for Adults with Type 2 Diabetes Print this page PLAINSBORO, N.J., Sept. 20, 2019 /PRNewswire/ — Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved Rybelsus (semaglutide) tablets 7 mg or 14 mg for adults with type 2 diabetes that… Read More »
In marriage, conflict is inevitable. Even the happiest couples argue. And research shows they tend to argue about the same topics as unhappy couples: children, money, in-laws, intimacy. So, what distinguishes happy couples? According to “What are the Marital Problems of Happy Couples? A Multimethod, Two-Sample Investigation,” a study published this August in Family Process,… Read More »
Innovators in the 16th century invented the kayak as a means of getting around. At that time, cruising along the river in your kayak would have been the equivalent of a drive down the freeway, though a bit more exciting. It was not, however, the popular recreational activity it is now.Modern kayaks are more frequently… Read More »
A patient in Illinois is the first to die of a mysterious lung illness linked to vaping, public health officials announced on Friday. The death occurred as doctors and hospitals nationwide report an increasing number of vaping-related respiratory illnesses this summer: 193 cases have now been reported in 22 states, including 22 cases in Illinois,… Read More »
By Dennis Thompson HealthDay Reporter FRIDAY, Aug. 23, 2019 (HealthDay News) — An Illinois resident who was hospitalized after suffering severe respiratory illness related to vaping has died, state health officials reported Friday. In addition, the number of reported cases of people who have used e-cigarettes or vaped and have been hospitalized with respiratory symptoms… Read More »
LONDON (Reuters) – Scientists are a step closer to finding the first effective treatments for the deadly Ebola haemorrhagic fever after two potential drugs showed survival rate of as much as 90% in a clinical trial in Congo. Two experimental drugs – Regeneron’s (REGN.O) REGN-EB3 and a monoclonal antibody called mAb114 – were both developed… Read More »